Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Notch | 3 | 2020 | 203 | 1.050 |
Why?
|
| Osteogenesis | 4 | 2020 | 155 | 1.040 |
Why?
|
| Growth Plate | 2 | 2022 | 20 | 0.930 |
Why?
|
| Chondrogenesis | 3 | 2022 | 26 | 0.910 |
Why?
|
| Chondrocytes | 3 | 2022 | 48 | 0.770 |
Why?
|
| Bone Development | 4 | 2025 | 57 | 0.750 |
Why?
|
| Signal Transduction | 5 | 2020 | 4542 | 0.700 |
Why?
|
| Zebrafish | 2 | 2022 | 388 | 0.700 |
Why?
|
| Bone Diseases | 1 | 2020 | 44 | 0.660 |
Why?
|
| Osteoblasts | 4 | 2025 | 150 | 0.640 |
Why?
|
| Bone and Bones | 4 | 2020 | 266 | 0.570 |
Why?
|
| Cell Differentiation | 8 | 2025 | 1929 | 0.500 |
Why?
|
| Losartan | 1 | 2015 | 35 | 0.480 |
Why?
|
| Stem Cells | 2 | 2020 | 702 | 0.420 |
Why?
|
| Bone Density | 1 | 2015 | 320 | 0.400 |
Why?
|
| Receptor, Notch2 | 1 | 2012 | 8 | 0.400 |
Why?
|
| Receptor, Notch1 | 1 | 2012 | 64 | 0.390 |
Why?
|
| Cartilage | 3 | 2022 | 49 | 0.350 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 324 | 0.350 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 282 | 0.350 |
Why?
|
| RANK Ligand | 2 | 2025 | 52 | 0.350 |
Why?
|
| Osteoclasts | 5 | 2025 | 55 | 0.340 |
Why?
|
| Osteochondrodysplasias | 2 | 2022 | 68 | 0.330 |
Why?
|
| MicroRNAs | 2 | 2017 | 842 | 0.330 |
Why?
|
| Bone Neoplasms | 3 | 2020 | 429 | 0.320 |
Why?
|
| Mice, Transgenic | 7 | 2024 | 2410 | 0.320 |
Why?
|
| Muscle, Skeletal | 1 | 2013 | 954 | 0.270 |
Why?
|
| Animals | 19 | 2025 | 34184 | 0.260 |
Why?
|
| DNA Helicases | 2 | 2025 | 227 | 0.250 |
Why?
|
| Jagged-1 Protein | 2 | 2017 | 53 | 0.240 |
Why?
|
| X-linked Nuclear Protein | 1 | 2025 | 17 | 0.240 |
Why?
|
| Mice | 14 | 2025 | 17746 | 0.240 |
Why?
|
| SOX9 Transcription Factor | 2 | 2017 | 80 | 0.230 |
Why?
|
| Membrane Proteins | 1 | 2012 | 1527 | 0.230 |
Why?
|
| Transforming Growth Factor beta | 2 | 2017 | 459 | 0.200 |
Why?
|
| Nuclear Proteins | 2 | 2025 | 1272 | 0.170 |
Why?
|
| Diphosphonates | 1 | 2020 | 38 | 0.170 |
Why?
|
| Nitrogen | 1 | 2020 | 145 | 0.170 |
Why?
|
| Mice, Knockout | 2 | 2025 | 3753 | 0.160 |
Why?
|
| Nerve Tissue Proteins | 1 | 2025 | 1113 | 0.150 |
Why?
|
| Homeostasis | 2 | 2020 | 692 | 0.140 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 2538 | 0.140 |
Why?
|
| Radiography | 3 | 2015 | 828 | 0.140 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2017 | 213 | 0.140 |
Why?
|
| Osteocytes | 1 | 2017 | 15 | 0.140 |
Why?
|
| Micrognathism | 2 | 2017 | 66 | 0.140 |
Why?
|
| Hand Deformities, Congenital | 1 | 2017 | 89 | 0.130 |
Why?
|
| Ubiquitination | 1 | 2017 | 174 | 0.130 |
Why?
|
| Iliac Artery | 1 | 2016 | 93 | 0.130 |
Why?
|
| Limb Deformities, Congenital | 2 | 2015 | 106 | 0.130 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 4357 | 0.120 |
Why?
|
| Angiotensins | 1 | 2015 | 8 | 0.120 |
Why?
|
| Mutation, Missense | 2 | 2017 | 868 | 0.120 |
Why?
|
| RAW 264.7 Cells | 1 | 2015 | 39 | 0.120 |
Why?
|
| Actins | 1 | 2017 | 342 | 0.120 |
Why?
|
| RecQ Helicases | 1 | 2015 | 60 | 0.120 |
Why?
|
| Hypertrophy | 1 | 2015 | 102 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2015 | 96 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2015 | 113 | 0.120 |
Why?
|
| DNA-Binding Proteins | 2 | 2017 | 2058 | 0.110 |
Why?
|
| Exome | 3 | 2017 | 1042 | 0.110 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 667 | 0.110 |
Why?
|
| Cleidocranial Dysplasia | 1 | 2013 | 6 | 0.110 |
Why?
|
| Flavoproteins | 1 | 2013 | 17 | 0.110 |
Why?
|
| Sialoglycoproteins | 1 | 2013 | 48 | 0.110 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2013 | 14 | 0.110 |
Why?
|
| Mutation | 4 | 2017 | 5811 | 0.100 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2013 | 59 | 0.100 |
Why?
|
| Bone Remodeling | 1 | 2013 | 56 | 0.100 |
Why?
|
| Ectodermal Dysplasia | 1 | 2013 | 45 | 0.100 |
Why?
|
| Nucleoside Transport Proteins | 1 | 2012 | 6 | 0.100 |
Why?
|
| Osteosclerosis | 1 | 2012 | 12 | 0.100 |
Why?
|
| Osteopetrosis | 1 | 2012 | 14 | 0.100 |
Why?
|
| Serrate-Jagged Proteins | 1 | 2012 | 38 | 0.100 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2012 | 84 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 1017 | 0.100 |
Why?
|
| Carrier Proteins | 1 | 2017 | 1026 | 0.090 |
Why?
|
| Osteoporosis | 1 | 2012 | 116 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2015 | 1624 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 724 | 0.090 |
Why?
|
| Intellectual Disability | 1 | 2017 | 1061 | 0.080 |
Why?
|
| Transcription Factors | 3 | 2017 | 2609 | 0.080 |
Why?
|
| Osteosarcoma | 1 | 2012 | 259 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 1664 | 0.080 |
Why?
|
| Humans | 14 | 2024 | 124793 | 0.070 |
Why?
|
| Cytochrome P-450 CYP2B1 | 1 | 2006 | 1 | 0.070 |
Why?
|
| Retinoid X Receptors | 1 | 2006 | 33 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 3142 | 0.070 |
Why?
|
| Phenobarbital | 1 | 2006 | 36 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 4431 | 0.060 |
Why?
|
| Lysine | 1 | 2006 | 197 | 0.060 |
Why?
|
| alpha-Thalassemia | 1 | 2025 | 13 | 0.060 |
Why?
|
| Osteoprotegerin | 1 | 2025 | 10 | 0.060 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2025 | 74 | 0.060 |
Why?
|
| Gene Knock-In Techniques | 1 | 2024 | 123 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2006 | 389 | 0.050 |
Why?
|
| Histones | 1 | 2006 | 534 | 0.050 |
Why?
|
| Molecular Sequence Data | 3 | 2013 | 3881 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2006 | 820 | 0.050 |
Why?
|
| Alendronate | 1 | 2020 | 19 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2025 | 1001 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2017 | 3061 | 0.040 |
Why?
|
| Collagen Type II | 1 | 2017 | 24 | 0.030 |
Why?
|
| Female | 4 | 2017 | 66553 | 0.030 |
Why?
|
| RNA Splice Sites | 1 | 2017 | 87 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2017 | 112 | 0.030 |
Why?
|
| Protein Stability | 1 | 2017 | 165 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 121 | 0.030 |
Why?
|
| Hindlimb | 1 | 2016 | 76 | 0.030 |
Why?
|
| Multigene Family | 1 | 2017 | 297 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 207 | 0.030 |
Why?
|
| Lung | 1 | 2024 | 1491 | 0.030 |
Why?
|
| Face | 1 | 2017 | 180 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2017 | 412 | 0.030 |
Why?
|
| Base Sequence | 2 | 2013 | 3099 | 0.030 |
Why?
|
| Patella | 1 | 2015 | 25 | 0.030 |
Why?
|
| Radius | 1 | 2015 | 25 | 0.030 |
Why?
|
| Homozygote | 1 | 2017 | 534 | 0.030 |
Why?
|
| Heterozygote | 1 | 2017 | 676 | 0.030 |
Why?
|
| Rothmund-Thomson Syndrome | 1 | 2015 | 48 | 0.030 |
Why?
|
| Anal Canal | 1 | 2015 | 80 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 886 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2017 | 753 | 0.030 |
Why?
|
| Dwarfism | 1 | 2015 | 100 | 0.030 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2015 | 120 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2017 | 759 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 2 | 2013 | 1761 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 537 | 0.030 |
Why?
|
| Calcification, Physiologic | 1 | 2013 | 22 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 777 | 0.030 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2013 | 25 | 0.030 |
Why?
|
| Pedigree | 1 | 2017 | 1595 | 0.030 |
Why?
|
| Protein Binding | 1 | 2017 | 1749 | 0.030 |
Why?
|
| Bone Resorption | 1 | 2013 | 42 | 0.030 |
Why?
|
| Femur | 1 | 2013 | 67 | 0.030 |
Why?
|
| Craniosynostoses | 1 | 2015 | 132 | 0.030 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2013 | 54 | 0.030 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2013 | 101 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 238 | 0.030 |
Why?
|
| Frameshift Mutation | 1 | 2013 | 180 | 0.020 |
Why?
|
| Consanguinity | 1 | 2012 | 104 | 0.020 |
Why?
|
| Gene Expression | 1 | 2017 | 1570 | 0.020 |
Why?
|
| Organ Size | 1 | 2013 | 435 | 0.020 |
Why?
|
| Cell Line | 1 | 2017 | 2771 | 0.020 |
Why?
|
| Antibodies | 1 | 2013 | 372 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2013 | 348 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2012 | 626 | 0.020 |
Why?
|
| Disease Progression | 1 | 2016 | 2052 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 1291 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 1341 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2013 | 891 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 2704 | 0.020 |
Why?
|
| Genotype | 1 | 2013 | 2557 | 0.020 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2006 | 11 | 0.020 |
Why?
|
| Heterochromatin | 1 | 2006 | 49 | 0.020 |
Why?
|
| Nucleosomes | 1 | 2006 | 39 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 1697 | 0.020 |
Why?
|
| Dimerization | 1 | 2006 | 144 | 0.020 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2006 | 28 | 0.020 |
Why?
|
| Methylation | 1 | 2006 | 224 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2006 | 317 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2006 | 285 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2006 | 229 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 756 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2006 | 486 | 0.010 |
Why?
|
| Phenotype | 1 | 2013 | 4260 | 0.010 |
Why?
|
| Binding Sites | 1 | 2006 | 1297 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2006 | 1075 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2006 | 1704 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 19329 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 3338 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2006 | 938 | 0.010 |
Why?
|
| Infant | 1 | 2012 | 12482 | 0.010 |
Why?
|
| Child | 1 | 2017 | 24453 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2012 | 14050 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2006 | 1319 | 0.010 |
Why?
|
| Male | 1 | 2017 | 61283 | 0.010 |
Why?
|